People taking GLP-1 weight loss medications have found some easy ways to get in lots of protein at meals and snacks.

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

CNBC’s Angelica Peebles sits down with Lilly’s Head of Oncology, Jake Van Naarden, to discuss what’s next in Lilly’s oncology ...

As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...